PharmaJet , WHO and BMGF conduct Somalia Polio Vaccination Campaign

GOLDEN, Colo. — October 21, 2021 - PharmaJet® the maker of innovative, needle-free injection technology, today announced that its Tropis® intradermal needle-free injection system is being used in a campaign in Somalia delivering inactivated polio vaccine to more than 110,000 children. The purpose of the campaign, funded in part by the Bill and Melinda Gates Foundation, using PharmaJet’s needle-free delivery product, supplied by the World Health Organization (WHO), is to ensure children under 5 who missed their routine immunization, receive their full regimen of inactivated polio vaccine.

PharmaJet Presents Needle-free delivery of COVID-19 Vaccines and Beyond at World Vaccine Congress – Europe

GOLDEN, Colo. — October 12, 2021 - PharmaJet®, the maker of innovative, needle-free injection technology, announced that their latest partnerships and research results will be presented at the World Vaccine Congress - Europe on October 21. The presentation, entitled Needle-free Delivery: COVID-19 Vaccines and Beyond, is being presented by Erin K. Spiegel, PhD, Vice President, Clinical & Regulatory Affairs at PharmaJet, Inc.